Pharmaceuticals in North America - Market Summary, Competitive Analysis and Forecast, 2016-2025
Pharmaceuticals in North America - Market @Summary, Competitive Analysis and Forecast, 2016-2025
SUMMARY
Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The North American pharmaceuticals market had total revenues of $412.0bn in 2020, representing a compound annual growth rate (CAGR) of 4.5% between 2016 and 2020.
- The US pharmaceuticals market is the largest in the North American region, with a 93.9% market share. Comparatively, the Canadian and Mexican markets have a 4.9% and 1.2% market share respectively. As such, the performance of the US market has a significant influence on the North American market overall.
- Demographic factors are expected to sustain demand for pharmaceutical products against an uncertain regulatory background and the growing popularity of generic and biosimilar alternatives. North American countries are currently witnessing an ageing population and as health problems rise with age, seniors are more likely to report chronic conditions and accompanying poor health, which will continue to drive the need for pharmaceutical products.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts
- What was the size of the North America pharmaceuticals market by value in 2020?
- What will be the size of the North America pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the North America pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up North America's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent M&A activity?
7.5. How does government regulation impact leading players?
7.6. What impact is the COVID-19 pandemic having on the market?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca PLC
8.4. Merck & Co., Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent M&A activity?
7.5. How does government regulation impact leading players?
7.6. What impact is the COVID-19 pandemic having on the market?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca PLC
8.4. Merck & Co., Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: North America pharmaceuticals market value: $ billion, 2016-20
Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: North America pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: North America pharmaceuticals market share: % share, by value, 2020
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: Merck & Co., Inc.: key facts
Table 17: Merck & Co., Inc.: Annual Financial Ratios
Table 18: Merck & Co., Inc.: Key Employees
Table 19: Merck & Co., Inc.: Key Employees Continued
Table 20: North America exchange rate, 2016-20
Table 1: North America pharmaceuticals market value: $ billion, 2016-20
Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: North America pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: North America pharmaceuticals market share: % share, by value, 2020
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: Merck & Co., Inc.: key facts
Table 17: Merck & Co., Inc.: Annual Financial Ratios
Table 18: Merck & Co., Inc.: Key Employees
Table 19: Merck & Co., Inc.: Key Employees Continued
Table 20: North America exchange rate, 2016-20
LIST OF FIGURES
Figure 1: North America pharmaceuticals market value: $ billion, 2016-20
Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: North America pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in North America, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in North America, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in North America, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2020
Figure 10: North America pharmaceuticals market share: % share, by value, 2020
Figure 1: North America pharmaceuticals market value: $ billion, 2016-20
Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: North America pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in North America, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in North America, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in North America, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2020
Figure 10: North America pharmaceuticals market share: % share, by value, 2020
